Molecular determinants of response to PD-L1 blockade across tumor types
PD-L1 immune checkpoint inhibition has been used for several tumour types. Here, the authors use immunohistochemistry, tumour mutation burden and RNA-seq data from 366 patients with different indications to identify molecular signatures of response to atezolizumab and reveal pathway heterogeneity an...
Enregistré dans:
Auteurs principaux: | Romain Banchereau, Ning Leng, Oliver Zill, Ethan Sokol, Gengbo Liu, Dean Pavlick, Sophia Maund, Li-Fen Liu, Edward Kadel, Nicole Baldwin, Suchit Jhunjhunwala, Dorothee Nickles, Zoe June Assaf, Daniel Bower, Namrata Patil, Mark McCleland, David Shames, Luciana Molinero, Mahrukh Huseni, Shomyseh Sanjabi, Craig Cummings, Ira Mellman, Sanjeev Mariathasan, Priti Hegde, Thomas Powles |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ae29efdfced64f11b4172bdb2e1a8bde |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Both T cell priming in lymph node and CXCR3-dependent migration are the key events for predicting the response of atezolizumab
par: Toshiki Iwai, et autres
Publié: (2021) -
The Seven Earths and Seven Heavens in the Light of Jung, Maslow and Hindu Psychology
par: Bharat Jhunjhunwala
Publié: (2021) -
Development of Inflammatory Bowel Disease Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice
par: Thomas Sharpton, et autres
Publié: (2017) -
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
par: Yu Kong, et autres
Publié: (2019) -
Ejercicio de construcción de un ideal-tipo de la vida social: el caso del emprendedor /
par: Toledo Nickles, Ulises
Publié: (2001)